FDA backs Glaxo's vaccine Cervarix for women

WASHINGTON (AP) -- Federal health officials favor approving GlaxoSmithKline's long-delayed vaccine Cervarix to prevent the leading cause of cervical cancer in U.S. women.

The Food and Drug Administration's vaccine panel voted overwhelmingly that the vaccine appears safe and effective for girls and women ages 10 to 25.

If the FDA follows the group's advice, Glaxo would begin competing against Merck's vaccine Gardasil, which has controlled the U.S. market since 2006.

Cervarix's launch was delayed in 2007 when the FDA said it needed more data on the vaccine.

Panelists say newer studies suggest the vaccine is safe, but they recommend follow-up studies to monitor miscarriages and muscular problems reported by a small number of patients.

(Copyright 2009 by The Associated Press. All Rights Reserved.)


Join the Conversation!

To comment, the following rules must be followed:

  • No Obscenity, Profanity, Vulgarity, Racism or Violent Descriptions
  • No Negative Community Comparisons
  • No Fighting, Name-calling, or Personal Attacks
  • Multiple Accounts are Not Allowed
  • Stay on Story Topic

Comments may be monitored for inappropriate content, but the station is under no legal obligation to do so.
If you believe a comment violates the above rules, please use the Flagging Tool to alert a Moderator.
Flagging does not guarantee removal.

Multiple violations may result in account suspension.
Decisions to suspend or unsuspend accounts are made by Station Moderators.
Links require admin approval before posting.
Questions may be sent to webmaster@wvlt-tv.com. Please provide detailed information.

powered by Disqus

WVLT VOLUNTEER TV

6450 Papermill Drive Knoxville, TN 37919 Phone - (865) 450-8888; Fax - (865) 450-8869
Copyright © 2014 WVLT-TV Inc. - Designed by Gray Digital Media - Powered by Clickability 58130307 - local8now.com/a?a=58130307
Gray Television, Inc.